Immunocore Holdings IMCR
NASDAQ IMCR
$36.13 -1.44 (-3.85%)
As of: Sep 4, 2026 · 3:59 PM EDT

Immunocore Holdings (IMCR) Exchange Rate Effect (2021 - 2026)

Immunocore Holdings (IMCR) posted Exchange Rate Effect of -$6.1 million for Q1 2026, down 322.16% sequentially from -$1.5 million in Q4 2025, and down 172.8% YoY from $8.4 million in Q1 2025.

Analysis

Immunocore Holdings (IMCR) Exchange Rate Effect (2021 - 2026) Analysis & Trends

Immunocore Holdings has reported Exchange Rate Effect for 6 years, with the latest figure at -$6.1 million in Q1 2026.

  • Quarterly Exchange Rate Effect fell 172.8% year-over-year to -$6.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.1 million (up 60.93% YoY) and the FY2025 annual result came in at $26.7 million, up 1660.83% from the prior year.
  • Exchange Rate Effect fell to -$6.1 million in Q1 2026 per IMCR's latest filing, from -$1.5 million in the prior quarter.
  • Over five years, Exchange Rate Effect peaked at $15.7 million in Q3 2022 and troughed at -$23.3 million in Q4 2022.
  • A 5-year average of $1.3 million and a median of $2.2 million in 2023 frame the typical range for Exchange Rate Effect.
  • The sharpest annual moves came in 2022 and 2025: Exchange Rate Effect slumped 215504.37% in 2022, then surged 7564.15% in 2025.
  • Over 5 years, Exchange Rate Effect stood at -$23.3 million in 2022, then surged by 146.38% to $10.8 million in 2023, then plunged by 220.86% to -$13.0 million in 2024, then soared by 88.85% to -$1.5 million in 2025, then tumbled by 322.16% to -$6.1 million in 2026.
  • According to Business Quant data, Exchange Rate Effect over the past three periods registered -$6.1 million, -$1.5 million, and $7.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Exchange Rate Effect (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -3.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -300,000.00
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -2.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 19.84 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -2.45 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -287,000.00
10 Immunocore Holdings 1.85 Bn 965.54 Mn 114.84 Mn 618,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 618,000.00
Mar 31, 2026 -6.13 Mn
Dec 31, 2025 -1.45 Mn
Sep 30, 2025 7.82 Mn
Jun 30, 2025 11.87 Mn
Mar 31, 2025 8.43 Mn
Dec 31, 2024 -13.03 Mn
Sep 30, 2024 12.29 Mn
Jun 30, 2024 -159,000.00
Mar 31, 2024 -800,000.00
Dec 31, 2023 10.78 Mn
Sep 30, 2023 -8.11 Mn
Jun 30, 2023 3.39 Mn
Mar 31, 2023 2.23 Mn
Dec 31, 2022 -23.25 Mn
Sep 30, 2022 15.69 Mn
Dec 31, 2021 -10,784.08